Summary
In order to overcome the difficulties and risks involved in production of HDC rabies vaccine for human use, a new tissue culture rabies vaccine for use in man has been developed. The Flury LEP-C25 strain was propagated in primary chick embryo cells (CEC), the tissue culture fluid was purified and concentrated by continuous density gradient centrifugation and inactivated by betapropiolactone. The antigen concentrates were tested by the modified antibody binding test and the vaccine adjusted to contain >2.5IU per dose. It was imposed that this vaccine should match the high standards of potency and tolerability achieved in the field by the HDC-vaccine. Therefore, this vaccine had to undergo numerous laboratory trials before clinical tests in man were considered.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Wiktor TJ, Plotkin SA, Koprowski H (1978) Development and clinical trials of the new human rabies vaccine of tissue culture (human diploid cell) origin. Develop biol Standard 40:3–9
Barth R, Groß-Albenhausen E, Jaeger O, Milcke L (1981) The antibody binding test, a useful method for quantitative determination of inactivated rabies virus antigen. J biol Stand 9:81–89
Barth R, Gruschkau H, Jaeger O, Milcke L (1982) Purification, concentration and evaluation of rabies virus antigen. Comp Immun Microbiol Infect Dis 5:211–216
Barth R, Gruschkau H, Bijok U, Hilfenhaus J, Hinz J, Milcke L, Moser H, Jaeger O, Ronneberger H, Weinmann E (in press) A new inactivated tissue culture rabies vaccine for use in man. Evaluation by laboratory tests. J biol Stand
Rosanoff EJ (1979) The potency of rabies vaccines as determined by the induction of antibody in mice. J Biol Stand 7:1–7
Baer GM, Yager Pamela (1977) A mouse model for post-exposure rabies prophylaxis: the comparative efficacy of two vaccines and of antiserum administration. J Gen Virology 36:51–58
Mifune K, Shighijo A, Makino Y, Takeughi E, Aymada A, Sakamoto K (1980) A mouse model for the pathogenesis and postexposure prophylaxis of rabies. Microbiol Immunol 24(9): 835–845
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Springer-Verlag Berlin, Heidelberg
About this paper
Cite this paper
Barth, R., Bijok, U., Gruschkau, H., Jaeger, O., Weinmann, E. (1985). Purified Chick Embryo Cell (PCEC) Rabies Vaccine for Human Use — Laboratory Data. In: Kuwert, E., Mérieux, C., Koprowski, H., Bögel, K. (eds) Rabies in the Tropics. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70060-6_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-70060-6_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-13826-6
Online ISBN: 978-3-642-70060-6
eBook Packages: Springer Book Archive